AngioDynamics, Inc. (NASDAQ:ANGO) Shares Purchased by Manatuck Hill Partners LLC

Manatuck Hill Partners LLC grew its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 166.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 199,500 shares of the medical instruments supplier's stock after purchasing an additional 124,500 shares during the period. Manatuck Hill Partners LLC owned about 0.49% of AngioDynamics worth $1,827,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of ANGO. Barclays PLC grew its stake in AngioDynamics by 81.0% during the 3rd quarter. Barclays PLC now owns 83,582 shares of the medical instruments supplier's stock worth $651,000 after buying an additional 37,394 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of AngioDynamics by 5.1% during the 3rd quarter. Geode Capital Management LLC now owns 960,767 shares of the medical instruments supplier's stock valued at $7,477,000 after buying an additional 46,409 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in AngioDynamics by 28.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 553,161 shares of the medical instruments supplier's stock valued at $4,304,000 after buying an additional 123,271 shares in the last quarter. Moody National Bank Trust Division increased its position in shares of AngioDynamics by 70.2% during the fourth quarter. Moody National Bank Trust Division now owns 55,780 shares of the medical instruments supplier's stock worth $511,000 after purchasing an additional 23,003 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in shares of AngioDynamics by 21.3% in the fourth quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier's stock valued at $147,000 after purchasing an additional 2,832 shares during the last quarter. Institutional investors own 89.43% of the company's stock.

AngioDynamics Stock Performance

Shares of NASDAQ:ANGO traded down $0.02 during trading on Wednesday, hitting $8.61. The company's stock had a trading volume of 107,623 shares, compared to its average volume of 553,986. AngioDynamics, Inc. has a fifty-two week low of $5.47 and a fifty-two week high of $13.50. The company has a market capitalization of $349.75 million, a PE ratio of -1.53 and a beta of 0.58. The business has a 50 day moving average price of $9.44 and a two-hundred day moving average price of $9.27.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last posted its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.16. The firm had revenue of $72.00 million for the quarter, compared to the consensus estimate of $70.30 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The firm's revenue for the quarter was down 4.3% compared to the same quarter last year. As a group, equities analysts expect that AngioDynamics, Inc. will post -0.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a "buy" rating and set a $16.00 price objective (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.